[Seroprevalence of Helicobacter pylori anti-CagA antibodies and its relationship with epidemiologic factors in Santa Fe]
- PMID: 15328663
[Seroprevalence of Helicobacter pylori anti-CagA antibodies and its relationship with epidemiologic factors in Santa Fe]
Abstract
The early detection of anti-CagA antibodies in young adults would be of a great clinical impact in the prevention of gastric cancer. The aim of this study was to assess IgG and anti-CagA antibodies seroprevalence against Helicobacter pylori in our region using a non invasive technique, easy to perform an evaluating its relationship with different epidemiological risk factors. Four hundred and thirty-five volunteers with a mean age of forty years old from different health centers were included in this study. Demographic socieconomical and other data of interest were recorded. IgG and CagA antibodies against Helicobacter pylori were determined using an enzyme immunoassay technique. The prevalence of IgG antibodies was 52.2% being 152 in women (53.7%) and 75 in men (49%). These antibodies were showed in 65% of affected patients and 43.1% in asymptomatic carriers. The prevalence anti-CagA antibodies was 63.4% among seropositives (IgG) individuals corresponding to 33.1% of the total studied population. Ninety-six (33.9%) persons of this group were women an 48 (31.6%) were men. The prevalence was 45.4% and 25.7% in symptomatic an asymptomatic individuals, respectively. It was demonstrated that IgG antibodies were associated with age, area of residence, educational level reached and number of bedrooms in the house. The anti-CagA antibodies depend on area of residence and symptoms. The relation between the symptoms and the presence of anti-CagA antibodies shows the selective importance of clinical data in the gastric diseases associated with Helicobacter pylori.
Similar articles
-
[Helicobacter pylori genotypes and their association with host's immune response].Rev Gastroenterol Mex. 2002 Jul-Sep;67(3):155-60. Rev Gastroenterol Mex. 2002. PMID: 12653051 Spanish.
-
[Seroprevalence of Helicobacter pylori infection and anti-CagA positivity in the county Szabolcs-Szatmár-Bereg].Orv Hetil. 2003 Aug 31;144(35):1713-8. Orv Hetil. 2003. PMID: 14533352 Hungarian.
-
Age and severity of mucosal lesions influence the performance of serologic markers in Helicobacter pylori-associated gastroduodenal pathologies.Cancer Epidemiol Biomarkers Prev. 2008 Sep;17(9):2498-504. doi: 10.1158/1055-9965.EPI-08-0289. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18768521
-
Systematic review with meta-analysis: association between Helicobacter pylori CagA seropositivity and odds of inflammatory bowel disease.Aliment Pharmacol Ther. 2019 Jul;50(2):121-131. doi: 10.1111/apt.15306. Epub 2019 Jun 5. Aliment Pharmacol Ther. 2019. PMID: 31165513 Free PMC article.
-
Helicobacter pylori, musings from the epidemiologic armchair.Epidemiol Infect. 1992 Aug;109(1):81-5. Epidemiol Infect. 1992. PMID: 1499674 Free PMC article. Review.
Cited by
-
Specific serum immunoglobulin G to H pylori and CagA in healthy children and adults (south-east of Iran).World J Gastroenterol. 2007 Jun 14;13(22):3117-21. doi: 10.3748/wjg.v13.i22.3117. World J Gastroenterol. 2007. PMID: 17589930 Free PMC article.
-
Serum levels of high-sensitivity C-reactive protein (hs-CRP)in Helicobacter pylori-infected peptic ulcer patients and its association with bacterial CagA virulence factor.Dig Dis Sci. 2009 Dec;54(12):2612-6. doi: 10.1007/s10620-008-0686-z. Dig Dis Sci. 2009. PMID: 19160050
-
Lower circulating levels of chemokine CXCL10 in Helicobacter pylori-infected patients with peptic ulcer: Influence of the bacterial virulence factor CagA.Iran J Microbiol. 2013 Mar;5(1):28-35. Iran J Microbiol. 2013. PMID: 23467184 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical